Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Autor:
Elizabeth A. Raetz, Amrana Quereshi, M. Zwaan, Nirali N. Shah, Keith J. August, Mignon L. Loh, Susan R. Rheingold, Luciano Dalla-Pozza, Richard Sposto, Jean-Pierre Bourquin, Maryalice Stetler-Stevenson, Deepa Bhojwani, Constance M. Yuan, Sarah Alexander, Paul G. Schlegel, Aurelie Cabannes, Jennifer L. McNeer, Maureen M. O'Brien, Vilmarie Rodriguez, Claudia Rossig
Publikováno v:
Leukemia, 33(4), 884-892. Nature Publishing Group
Leukemia, vol 33, iss 4
Leukemia
Leukemia, vol 33, iss 4
Leukemia
Although inotuzumab ozogamicin (InO) is recognized as an effective agent in relapsed acute lymphoblastic leukemia (ALL) in adults, data on safety and efficacy in pediatric patients are scarce. We report the use of InO in 51 children with relapsed/ref